Conversations With Patients About Rheumatoid Arthritis, Cancer, and Biologics
John J. Cush, MD
Baylor University Medical Center |
Patient Registries in Rheumatoid Arthritis:
Opportunities and Challenges for Rheumatologists
Jeffrey Greenberg, MD, MPH
New York University School of Medicine |
Managing Risk in Patients with RA: Focus on Demyelinating Conditions
Leonard Calabrese, DO
Cleveland Clinic |
The Emerging Role of Electronic Health Records
in the Care of Patients with Rheumatoid Arthritis
Peter J. Embi, MD, MS
University of Cincinnati |
Long-Term Safety and Efficacy of DMARDs and Biologics in the
Treatment of Rheumatoid Arthritis
Roy Fleischmann, MD
University of Texas Southwestern Medical Center
Metroplex Clinical Research Center |
The Difficult RA Case: Inadequate Response to One or More Biologics
Michael H. Schiff, MD
University of Colorado School of Medicine |
Fall 2009 Conference Update: What's New in Biologics
Philip J. Mease, MD
Swedish Medical Center |
Immunizations in Autoimmune Disease
Clifton O. Bingham III, MD
Johns Hopkins University
|
Comorbidity in Patients with Rheumatoid Arthritis: What are the Real Concerns?
Stephen Paget, MD, FACP, FACR
Weill Cornell Medical College
|
Quantitatively-Driven Management of Rheumatoid Arthritis
Jonathan Kay, MD
University of Massachusetts Medical School
|
Applying Research to Your Practice: Focus on Nonbiologic DMARDs in 2009
Yusuf Yazici, MD
NYU Hospital for Joint Diseases
|
Rheumatoid Arthritis: The Heart of the Matter Assessing Cardiovascular Risk in Patients with Rheumatoid Arthritis
M. Elaine Husni, MD MPH
Cleveland Clinic, Cleveland Ohio
|
The Application of New ACR Recommendations in the Management of Rheumatoid Arthritis: A Case Study Approach
Kenneth G. Saag, MD, MSc
University of Alabama at Birmingham, Birmingham, Alabama
|
Safety of Novel Immunomodulatory Therapies
Arthur Kavanaugh, MD
University of California, San Diego
|
Failing a TNF Inhibitor: What About Switching?
Yusuf Yazici, MD
NYU Hospital for Joint Diseases
|
